BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8692283)

  • 1. The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.
    Schlicker E; Marr I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):290-4. PubMed ID: 8692283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.
    Kathmann M; Schlicker E; Göthert M
    Psychopharmacology (Berl); 1994 Dec; 116(4):464-8. PubMed ID: 7701050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
    Schlicker E; Kathmann M; Bitschnau H; Marr I; Reidemeister S; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):482-8. PubMed ID: 8740140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S; Sahm UG; Traiffort E; Tardivel-Lacombe J; Arrang JM; Schwartz JC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):590-6. PubMed ID: 9918563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.
    Schlicker E; Kathmann M; Reidemeister S; Stark H; Schunack W
    Br J Pharmacol; 1994 Aug; 112(4):1043-8. PubMed ID: 7952862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.
    Cools AR; Prinssen EP; Ellenbroek BA
    Psychopharmacology (Berl); 1995 Jun; 119(4):428-39. PubMed ID: 7480523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
    Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
    Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of clozapine metabolites and analogues to the histamine H3 receptor in rat brain cortex.
    Alves-Rodrigues A; Leurs R; Willems E; Timmerman H
    Arch Pharm (Weinheim); 1996; 329(8-9):413-6. PubMed ID: 8915103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
    Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
    Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
    Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of clozapine with the histamine H3 receptor in rat brain.
    Rodrigues AA; Jansen FP; Leurs R; Timmerman H; Prell GD
    Br J Pharmacol; 1995 Apr; 114(8):1523-4. PubMed ID: 7541279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.
    Kathmann M; Schlicker E; Detzner M; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):498-503. PubMed ID: 8114949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
    Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
    Porter JH; Varvel SA; Vann RE; Philibin SD; Wise LE
    Psychopharmacology (Berl); 2000 Apr; 149(2):189-93. PubMed ID: 10805615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium.
    Bymaster FP; Falcone JF
    Eur J Pharmacol; 2000 Mar; 390(3):245-8. PubMed ID: 10708730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain.
    Depoortere R; Perrault G; Sanger DJ
    Behav Pharmacol; 1997 Aug; 8(4):364-72. PubMed ID: 9832995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S; Ahlenius S
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.